antibiotics part ii
TRANSCRIPT
PowerPoint Presentation
Antibiotics part IIDr. Nabila HassanTropical medicine MDZagazig university
Medical important bacteriaLack cell wallmycoplasmaureaoplasma
flexiable spirochetesBorrelialeptospirallisTreponema
rigid cell wallfilamentousactinomycesmycobacterinocardiasimple unicellular
obligate intra cellularChylamadiaCoxillaEhrlichiaRickettsiafree living gram positivegram negative
Gram positiveStaphStreptenterococcipeptostreptococcus
BacillibacillusClostradiumcoyrneubacteriumEriseplothirixLactobacillusListeriapropnionibacterium
cocci
Gram negative organismscocciNiesseriamorexalleacinobacterBacillinon enteric bacilli
HaemophilusBordetellaLegionella BrucellaFrancisella tularensisPasteurellaYersinia PestisBartonella
pseudmonsenteric rodsenterobacilliEcherechiafuseobacteriumhelicobacterkleibacilliprevotellaproteusProvendeicaPseudomonossallemonellaserratiashigelliaVibrioYersinia
This difference is relative, as bacteriostatic drugs are often bactericidal at high concentrations and in the presence of host defence mechanisms.
In clinical practice, the distinction is seldom important unless the bodys defence mechanisms are depressed.BacteriostaticBactericidalErythromycinTetracyclinesChloramphenicolSulphonamidesTrimethoprimPenicillinsCephalosporinsAminoglycosidesCo-trimoxazole
Antibacterial agentMechanism of actionPenicillinsCephalosporinsMonobactamsVancomycinPolypeptide AntibioticsInhibition of cell wall synthesis
Cell wall and cell membraneQuinolonesInhibition of DNA gyraseRifampicinInhibition of RNA polymeraseAminoglycosidesTetracyclinesErythromycinChloramphenicolInhibition of protein synthesis TrimethoprimSulphonamidesInhibition of folic acid metabolism
New Classes of AntibioticsFour new classes of antibiotics have been brought into clinical use in the late 2000s and early 2010s:
Cyclic lipopeptides (such as daptomycin), Glycylcyclines (such as tigecycline), Oxazolidinones (such as linezolid),Lipiarmycins (such as fidaxomicin)
CASE STUDY
A45-year-old woman is undergoing chemotherapy for breast cancer. She presents 10 days after her last chemotherapy with fever (temperature >38.5C),
but no other symptoms except a sore throat and mouth. On examination, she looks well, there is oral mucositis, ears are normal, lungs are clear, and the central line site is clean.
The CXR, urinalysis, and biochemistry are normal. Her WBC is 800/mL and the absolute neutrophil count is low (90 mL/min and 30 mL/min: Dose adjustment not necessaryCrCl 15-30 mL/min: Decrease dose by 50%CrCl